A deep dive into the implications of the Replimune CRL that surprised insiders and investors, the role of new leadership at ...

A global survey of scientists and informaticians reveals growing AI investment across the biopharma value chain, but ...

Congruence secures a $5 million grant to advance innovative therapies for GBA1 Parkinson's disease, enhancing hope for ...

The acquisition led by Advent International will see the two AI-powered companies combine forces to improve the healthcare ...

Gen Li, president and founder of Phesi, spoke with Pharmaceutical Executive about issues pharma companies are having during ...

The side effects that come with many cancer treatments can cause people to delay or avoid treatment.

Copycats and false advertisements are also to blame for the increased threats. Stemming from social media testimonials all ...

Unlock the secrets of executive presence in pharma to inspire confidence, influence decisions, and elevate your leadership ...

Global leader in mother and childcare, Philips Avent, announced a partnership with March of Dimes to establish the modern-day ...

With reports that FDA’s AI Elsa is “confidently hallucinating” studies that don’t exist, the use of AI to streamline drug ...

The EVERSANA AI Accelerator is our dedicated center of excellence designed to harness the power of artificial intelligence ...

Neha Anand, Analyst, Biopharma Intelligence Services, Citeline, highlights Emrelis’ potential to broaden its clinical impact ...